News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|June 29, 2022

Future Perspectives in Renal Cell Carcinoma (RCC)

Author(s)Thomas Hutson, DO, PharmD

Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.

Advertisement

Episodes in this series

EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)
EP. 1 Treatment Options for Patients with Renal Cell Carcinoma (RCC)
EP. 2 Clinical Implications of the TIVO-3 Trial
EP. 2 Clinical Implications of the TIVO-3 Trial
EP. 3 Tivozanib: Adverse Event Profile and How Toxicities are Managed
EP. 3 Tivozanib: Adverse Event Profile and How Toxicities are Managed
EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC
EP. 4 Experience with Tivozanib in the 3rd Line Setting for Patients with RCC
EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)
Now Playing
EP. 5 Future Perspectives in Renal Cell Carcinoma (RCC)

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Image of Kidney

A Patients Navigation Guide to Stage 2 Clear Cell Renal Cell Carcinoma

ByRyan Scott
February 1st 2026
Image of kidney.

What to Know About Your Stage 1 ccRCC Diagnosis

ByRyan Scott
January 12th 2026
cancer diagnosis

Just Diagnosed with Cancer? Read This Before You Google Anything

ByChuck Stravin
January 9th 2026
kidney cancer

Understanding Your Stage 4 RCC Diagnosis: Insights on What to Expect

ByRyan Scott
January 5th 2026
Image of Kidney

Cognitive Health Gains Focus in Kidney Cancer Survivorship

ByRyan Scott
December 24th 2025
Advertisement
Advertisement

Trending on CURE

1

Biotin Supplements May Complicate Cancer Care, Research Shows

2

Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer

3

FDA to Review New Drug Combo for Previously Treated Metastatic Colorectal Cancer

4

Expert Insights: FDA Approval of Lymphir for Cutaneous T-Cell Lymphoma

5

Doctor Outlines Cervical Cancer Care, Side Effects, HPV Prevention

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.